Drug Shortage Report for PMS-CARBAMAZEPINE-CR
Report ID | 114174 |
Drug Identification Number | 02231543 |
Brand name | PMS-CARBAMAZEPINE-CR |
Common or Proper name | CARBAMEZAPINE CR |
Company Name | PHARMASCIENCE INC |
Market Status | DORMANT |
Active Ingredient(s) | CARBAMAZEPINE |
Strength(s) | 200MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 100, 500 |
ATC code | N03AF |
ATC description | ANTIEPILEPTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-05-07 |
Estimated end date | Unknown |
Actual end date | 2021-04-22 |
Shortage status | Resolved |
Updated date | 2021-04-23 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2020-05-07 | English | Compare |
v2 | 2020-05-07 | French | Compare |
v3 | 2020-05-08 | English | Compare |
v4 | 2021-04-23 | English | Compare |
Showing 1 to 4 of 4